Clin Mol Hepatol.
2024 Jan;30(1):129-133. 10.3350/cmh.2023.0356.
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- Affiliations
-
- 1Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea
- KMID: 2549394
- DOI: http://doi.org/10.3350/cmh.2023.0356
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
- Clinical impact of nonalcoholic fatty liver disease on other medical diseases
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
